– UK, Leeds – Pharmacy2U Ltd announced today that it has secured a £40 million investment to support the rapid growth of the repeat prescription service.
The cash injection follows a phenomenal period of high growth and the company is delighted to have secured investment from healthcare specialist investor G Square Capital and our current investor BGF, which was also involved in the financing.
The capital will be used to continue to bring much needed innovation to healthcare and maintain the same high level of service in the future.
Pharmacy2U believes digital transformation is essential to improving patient access to healthcare and easing the strain on the NHS. Pharmacy2U is passionate about showing patients how technology can help simplify and improve the way they manage their health & medication.
“Pharmacy2U is on a mission to help improve patient outcome in partnership with the NHS by managing repeat prescriptions from request to delivery, and we thank all our investors, our staff and our patients who are on the journey with us.” said CEO, Mark Livingstone.
For more information, visit www.pharmacy2u.co.uk/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.